(Q54573275)

1 June 2018

title

The degree of apoptosis as an immunostimulant for a DNA vaccine against HIV-1 infection. (English)

1 reference

1 June 2018

author name string

Yoshitsugu Kojima

1

1 reference

1 June 2018

Nao Jounai

2

1 reference

1 June 2018

Fumihiko Takeshita

3

1 reference

1 June 2018

Masatoshi Nakazawa

4

1 reference

1 June 2018

Kentaro Okuda

5

1 reference

1 June 2018

Setsuko Watabe

6

1 reference

1 June 2018

Ke-Qin Xin

7

1 reference

1 June 2018

Kenji Okuda

8

1 reference

1 June 2018

language of work or name

English

0 references

publication date

18 August 2006

1 reference

1 June 2018

published in

Vaccine

1 reference

1 June 2018

volume

25

1 reference

1 June 2018

issue

3

1 reference

1 June 2018

page(s)

438-445

1 reference

1 June 2018

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.007

1 reference

Immunization of non-human primates with DNA vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.007

Induction of immune responses by DNA vaccines in large animals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.007

DNA vaccines and apoptosis: to kill or not to kill?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.007

Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.007

Immature dendritic cells phagocytose apoptotic cells via alphavbeta5 and CD36, and cross-present antigens to cytotoxic T lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.007

Cancer therapy using a self-replicating RNA vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.007

Targeted antigen delivery to antigen-presenting cells including dendritic cells by engineered Fas-mediated apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.007

Apoptosis-mediated enhancement of DNA-raised immune responses by mutant caspases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.007

Immunomodulation by apoptosis-inducing caspases for an influenza DNA vaccine delivered by gene gun.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.007

Dendritic cells transfected with cytopathic self-replicating RNA induce crosspriming of CD8+ T cells and antiviral immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.007

Enhancement of both cellular and humoral responses to genetic immunization by co-administration of an antigen-expressing plasmid and a plasmid encoding the pro-apoptotic protein Bax.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.007

Anti-HIV env immunities elicited by nucleic acid vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.007

Prime-boost vaccination with plasmid DNA and a chimeric adenovirus type 5 vector with type 35 fiber induces protective immunity against HIV.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.007

Contribution of the rev gene to the immunogenicity of DNA vaccines targeting the envelope glycoprotein of HIV

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.007

Adjuvant formulations and delivery systems for DNA vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.007

Conversion of procaspase-3 to an autoactivating caspase by fusion to the caspase-2 prodomain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.007

Prodomain-dependent nuclear localization of the caspase-2 (Nedd2) precursor. A novel function for a caspase prodomain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.007

Apoptotic DNA fragmentation is detected by a semi-quantitative ligation-mediated PCR of blunt DNA ends

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.007

Cationic liposomes induce macrophage apoptosis through mitochondrial pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.007

Novel mechanism of hybrid liposomes-induced apoptosis in human tumor cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.007

Induction of potent humoral and cell-mediated immune responses following direct injection of DNA encoding the HIV type 1 env and rev gene products

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.007

Adjuvant effect of multi-CpG motifs on an HIV-1 DNA vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.007

Mucosal immunization with HIV-1 peptide vaccine induces mucosal and systemic cytotoxic T lymphocytes and protective immunity in mice against intrarectal recombinant HIV-vaccinia challenge

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.007

Second gene expression in bicistronic constructs using short synthetic intercistrons and viral IRES sequences

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.007

IRES-dependent second gene expression is significantly lower than cap-dependent first gene expression in a bicistronic vector

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.007

Composition and arrangement of genes define the strength of IRES-driven translation in bicistronic mRNAs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.007

High translation efficiency is mediated by the encephalomyocarditis virus internal ribosomal entry sites if the natural sequence surrounding the eleventh AUG is retained.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.007

Use of DNAs expressing HIV-1 Env and noninfectious HIV-1 particles to raise antibody responses in mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.007

Induction of systemic and mucosal immune responses to human immunodeficiency virus type 1 by a DNA vaccine formulated with QS-21 saponin adjuvant via intramuscular and intranasal routes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.007

inferred from DOI database lookup

7 January 2021

based on heuristic

Studies of the neutralizing activity and avidity of anti-human immunodeficiency virus type 1 Env antibody elicited by DNA priming and protein boosting

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.007

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2006.08.007

1 reference

1 June 2018

PubMed ID

17079059

1 reference

1 June 2018